CN1724040A - Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method - Google Patents
Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method Download PDFInfo
- Publication number
- CN1724040A CN1724040A CN 200510042938 CN200510042938A CN1724040A CN 1724040 A CN1724040 A CN 1724040A CN 200510042938 CN200510042938 CN 200510042938 CN 200510042938 A CN200510042938 A CN 200510042938A CN 1724040 A CN1724040 A CN 1724040A
- Authority
- CN
- China
- Prior art keywords
- parts
- fritillaria
- chinese patent
- patent medicine
- astragalus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 229940079593 drug Drugs 0.000 title claims description 22
- 238000000034 method Methods 0.000 title claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 47
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 19
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 19
- 238000010992 reflux Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 32
- 241000605372 Fritillaria Species 0.000 claims description 23
- 241001061264 Astragalus Species 0.000 claims description 21
- 235000006533 astragalus Nutrition 0.000 claims description 21
- 210000004233 talus Anatomy 0.000 claims description 21
- 241000202807 Glycyrrhiza Species 0.000 claims description 19
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 19
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 19
- 229940010454 licorice Drugs 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 18
- 241000218671 Ephedra Species 0.000 claims description 17
- 241000244269 Peucedanum Species 0.000 claims description 16
- 240000000599 Lentinula edodes Species 0.000 claims description 15
- 241001523383 Achnatherum Species 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 230000000306 recurrent effect Effects 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 241000334160 Isatis Species 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000935235 Fritillaria meleagris Species 0.000 claims 3
- 238000002156 mixing Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 7
- 229940107666 astragalus root Drugs 0.000 abstract description 2
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 239000010231 banlangen Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- GGWBHVILAJZWKJ-UHFFFAOYSA-N dimethyl-[[5-[2-[[1-(methylamino)-2-nitroethenyl]amino]ethylsulfanylmethyl]furan-2-yl]methyl]azanium;chloride Chemical compound Cl.[O-][N+](=O)C=C(NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
技术领域technical field
本发明属于中药领域,是专治小儿感冒,特别是治疗小儿反复感冒的药物及其制备方法。The invention belongs to the field of traditional Chinese medicines, and is a medicine for treating children's colds, especially recurrent children's colds and a preparation method thereof.
背景技术Background technique
近年来,由于全球气候变化异常,加之大气污染、病原体变异等因素,感冒,特别是小儿感冒的发病率一直居高不下,小儿反复感冒的情况日趋增多。小儿体质虚弱、多病,易患感冒,且易加重、易反复。现代医学研究表明,小儿感冒的病因比较复杂。从传统的中医学角度看:小儿为稚阳之体,阴气未胜,阳气柔弱,形体未充,肌腠疏薄,卫外机能未固;或因其他原因导致小儿正气不足而不能御邪,固而反复发病,且所患病易实易虚,易寒易热。总之,祖国医学与现代医学对反复感冒儿童的认识是一脉相通的。目前治疗小儿感冒的中西药物很多,基本上是消炎(解毒)、退烧(清热)、止咳类的药物,起着对症状予以缓解的作用。就目前的中药而言,治疗小儿感冒的中成药的针对性较单一,如市场上的“儿感退热宁口服液”主治小儿外感发烧、头痛、咳嗽,“小儿咳喘灵”主治小儿上呼吸道感染、气管炎、肺炎。这些药物的治疗面普遍较窄,特别是对小儿反复感冒的病症,目前还没有更理想的药物。In recent years, due to abnormal global climate change, air pollution, pathogen variation and other factors, the incidence of colds, especially children's colds, has been high, and children's repeated colds are increasing day by day. Children are weak and sickly, prone to colds, and easily aggravated and repeated. Modern medical research shows that the etiology of children's colds is more complicated. From the point of view of traditional Chinese medicine: children are in the body of immature yang, the yin qi is not strong, the yang qi is weak, the body is not full, the muscles are thin, and the external defense function is not solid; Evil, solid and recurrent disease, and the disease is easy to be full and easy to be empty, easy to cold and easy to heat. In short, the understanding of children with recurrent colds in traditional Chinese medicine and modern medicine is in the same vein. There are many Chinese and Western medicines for the treatment of children's colds at present, which are basically anti-inflammatory (detoxification), antipyretic (heat-clearing) and cough-relieving medicines, which play a role in relieving symptoms. As far as the current traditional Chinese medicine is concerned, the specificity of Chinese patent medicines for treating colds in children is relatively single. For example, "Ergan Tuirening Oral Liquid" on the market is mainly used for children with exogenous fever, headache, and cough, and "Xiaoer Kechuanling" is mainly used for children with upper respiratory tract infections. Respiratory tract infection, bronchitis, pneumonia. The treatment range of these medicines is generally narrower, especially to the disease of children's recurrent colds, there is no more ideal medicine at present.
发明内容Contents of the invention
本发明所要解决的问题是提供一种适用于小儿气虚经常感冒及所引起的发烧、咳嗽、气喘、咽喉肿痛的药物,即提供一种治疗小儿感冒及反复感冒的中成药及其制备方法。The problem to be solved by the present invention is to provide a kind of medicine that is suitable for children with qi deficiency and frequent colds and the resulting fever, cough, asthma, and sore throat, that is, to provide a Chinese patent medicine for treating children with colds and recurrent colds and a preparation method thereof.
本申请人认为:小儿形体未充,肌腠疏薄,卫外机能未固,加以外界气候的变化,尚未能很好适应,故特别易为风邪所侵。本申请人提出的治疗原则是:益气疏表,清热解毒,止咳平喘,扶正与祛邪兼顾。The applicant thinks that children's bodies are not full, their muscles are sparse and interstitial, their external defense functions are not solid, and they have not been able to adapt well to changes in the external climate, so they are particularly vulnerable to invasion by wind and evil. The treatment principles proposed by the applicant are: nourishing qi and dredging the exterior, clearing away heat and detoxification, relieving cough and relieving asthma, taking into account both strengthening the body and eliminating pathogenic factors.
基于上述原则,本发明所提供的治疗小儿感冒及反复感冒的中成药主要由下列重量份数的原料药制成:Based on the above principles, the Chinese patent medicine for treating infantile colds and recurrent colds provided by the present invention is mainly made of the following raw materials in parts by weight:
鬼针草5~15份,野菊花5~15份,西洋参1~4份,黄芪20~40份,板蓝根15~20份,前胡4~8份,贝母3~8份,麻黄1.5~4份,甘草4~8份,香菇9.5~12.5份。5-15 parts of ghost needle grass, 5-15 parts of wild chrysanthemum, 1-4 parts of American ginseng, 20-40 parts of astragalus, 15-20 parts of isatidis root, 4-8 parts of peucedanum, 3-8 parts of Fritillaria, 1.5-4 parts of ephedra 4 parts, 4-8 parts of licorice, 9.5-12.5 parts of shiitake mushrooms.
各原料药在上述范围内均有较好的疗效,并得到了临床试验的证明。All raw materials have good curative effect within the above range, and have been proved by clinical trials.
在上述药物中,鬼针草(参见湖南省卫生厅1993年版《湖南省中药材标准》219~220页)、野菊花为君药。鬼针草具有发汗解热,清热解毒,散瘀消肿的作用;野菊花具有疏风清热,消肿解毒作用,二药合用可以相互加强疏散风热、清热解毒、利咽止痛、清肺止咳的作用;Among the above-mentioned medicines, Guizhengcao (see pages 219-220 of "Standards of Traditional Chinese Medicinal Materials in Hunan Province" published by Hunan Provincial Department of Health in 1993) and wild chrysanthemum are the king medicines. Ghost needle grass has the functions of sweating and relieving heat, clearing heat and detoxification, dispelling blood stasis and reducing swelling; wild chrysanthemum has the functions of dispelling wind and clearing heat, reducing swelling and detoxifying, the combination of the two medicines can strengthen each other to evacuate wind-heat, clear heat and detoxify, relieve throat pain, clear lung and relieve cough role;
西洋参、黄芪为臣药。西洋参的补气作用接近人参,但其性凉、味甘、微苦,不但清虚热、养阴治燥咳,而且也可清实火,且有止咳作用,尤其适宜小儿感冒肺热咳嗽、烦渴之症。故选用西洋参一方面借用它扶正固本的作用,另外,也因其性凉,能加强清热和止咳的作用。黄芪能补虚损,因其味轻,故专于气分而达表,所以能补元阳、充腠理,特别适用于体虚感冒。这里需要说明的是:对于黄芪,曾有人认为黄芪虽益卫但固汗而言其不宜用于外感发烧。其实不然,黄芪对表虚自汗可止,同时对表邪无汗,其又可以济津液以助汗。所以,选用西洋参和黄芪,一补内为主,一补外为主,相辅相成,相得益彰,使扶正固本之力加强,祛邪之力也相应增加。American ginseng and astragalus are ministerial medicines. American ginseng is similar to ginseng in invigorating qi, but it is cool in nature, sweet in taste, and slightly bitter. Polydipsia. Therefore, the choice of American ginseng not only borrows its function of strengthening the body, but also because of its cool nature, it can strengthen the effect of clearing away heat and relieving cough. Astragalus can tonify deficiency and damage. Because of its light taste, it is specialized in expressing Qi, so it can nourish Yuanyang and replenish interstitial organs. It is especially suitable for colds due to physical deficiency. What needs to be explained here is: Regarding Astragalus, some people once thought that although Astragalus is good for health, it should not be used for fever caused by exogenous factors. In fact, it is not the case. Astragalus can stop spontaneous sweating for external deficiency, and at the same time it can relieve external evils without sweating, and it can also stimulate body fluid to help sweat. Therefore, American ginseng and astragalus are selected, one is mainly to nourish the inside, and the other is mainly to nourish the outside.
上述君、臣药相结合,形成了扶正祛邪的基本格局,祛邪而不伤正,扶正而不留邪,这样的组合正适合小儿稚阳未充,稚阴未长生理特点的外感发烧之症。The combination of the above-mentioned monarch and minister medicines has formed the basic pattern of strengthening the body and eliminating the evil, eliminating the evil without hurting the body, strengthening the body without retaining the evil, this combination is just suitable for children with fever caused by exogenous factors that are not yet full of immature yang and immature yin. disease.
板蓝根、前胡、贝母、麻黄、甘草、香菇六味药为佐使药。其中,前胡能宣散风热,麻黄也具有辛散解热作用,二药与君药鬼针草配伍,解热发汗,宣散风热作用倍增;板蓝根清热解毒,凉血利咽,与君药配伍可以加强清热解毒作用;贝母、麻黄、前胡、甘草四味药配伍可以起到止咳平喘、祛痰的作用,其中,麻黄以平喘为主,前胡以祛痰为主,贝母、甘草以止咳为主;香菇(参见广西壮族自治区卫生厅1996年版《广西中药材标准》第二册181~182页)具有益胃气、化痰理气、维生素补偿剂的作用,它与臣药西洋参、黄芪同用,益肺气,健脾胃作用力加强;甘草也作使药用,以止咳为主,还可以矫味,调和诸药。Banlangen, Peucedanum, Fritillaria, Ephedra, Licorice, and Mushrooms are used as adjuvant medicines. Among them, Qianhu can disperse wind-heat, and ephedra also has pungent and antipyretic effects. The two drugs are compatible with the monarch drug Guizhencao, antipyretic and sweating, and the effect of dispersing wind-heat is doubled; Compatibility can strengthen the heat-clearing and detoxifying effect; the compatibility of the four herbs of Fritillaria, Ephedra, Peucedanum, and Licorice can relieve cough, relieve asthma, and eliminate phlegm. Licorice and licorice are mainly used to relieve cough; shiitake mushrooms (see pages 181-182 of the second volume of "Guangxi Traditional Chinese Medicinal Materials Standards" 1996 edition of the Health Department of Guangxi Zhuang Autonomous Region) have the functions of nourishing stomach qi, reducing phlegm and regulating qi, and vitamin supplements. American ginseng and astragalus are used together to benefit lung qi and invigorate the spleen and stomach; licorice is also used medicinally, mainly to relieve cough, and can also adjust the flavor and reconcile various medicines.
本药物组合的益气之药较多,但所选益气之药多温而不燥,且主要益气成分——西洋参还性凉,具有清肺热止咳作用,不但不影响鬼针草、板蓝根、野菊花的表里双清,反而还会增加它们的作用。由此可见,上述组合使各药物的功效产生协同作用,大量临床试验也证明其疗效是十分显著的。There are many qi-enhancing medicines in this medicine combination, but the selected qi-invigorating medicines are warm but not dry, and the main qi-invigorating ingredient—American ginseng is also cool in nature, which has the effect of clearing lung heat and relieving cough, not only does not affect ghost needle grass, Radix Isatidis and wild chrysanthemum are both clear on the outside and inside, which will actually increase their effects. It can be seen that the above-mentioned combination makes the efficacy of each drug produce a synergistic effect, and a large number of clinical trials have also proved that its curative effect is very significant.
本发明所选用的西洋参、黄芪、香菇还可以提高人体抵抗病邪的能力,即具有增强肌体免疫力的功效。The American ginseng, astragalus root and shiitake mushroom selected in the present invention can also improve the ability of the human body to resist pathogenic factors, that is, it has the effect of enhancing the immunity of the human body.
上述药物中的贝母最好选用浙贝母,浙贝母苦寒较重,开泄力大,清火散结作用较强。The Fritillaria in the above-mentioned medicines is best to choose Fritillaria Fritillaria, because Fritillaria Fritillaria is more bitter and cold, has a strong excretory power, and has a stronger effect of clearing away fire and dissipating stagnation.
上述药物中还可以另加入10~30重量份的蜂蜜作为矫味剂,蜂蜜本身也有益气健脾、润肺止咳的药理作用,且加入后使药物的口感较好。当然也可用蔗糖作矫味剂。10-30 parts by weight of honey can also be added to the above-mentioned medicine as a flavoring agent. The honey itself also has the pharmacological effects of benefiting qi and invigorating the spleen, moistening the lung and relieving cough, and the medicine tastes better after being added. Of course, sucrose can also be used as a flavoring agent.
本发明的优选用量范围为:鬼针草10~15份,野菊花6~10份,西洋参1.5~3份,黄芪25~35份,板蓝根15~20份,前胡5~7份,贝母3~5份,麻黄1.5~2.5份,甘草5~7份,香菇9.5~11份。The preferred dosage range of the present invention is: 10-15 parts of ghost needle grass, 6-10 parts of wild chrysanthemum, 1.5-3 parts of American ginseng, 25-35 parts of astragalus, 15-20 parts of Radix Radix, 5-7 parts of Radix Peucedanum, Fritillaria fritillaria 3 to 5 parts, 1.5 to 2.5 parts of ephedra, 5 to 7 parts of licorice, and 9.5 to 11 parts of shiitake mushrooms.
本发明的优选剂型为口服液,其它形式的口服剂型,如糖浆剂、颗粒剂、胶囊剂、片剂、丸剂等也属于本发明的范畴。The preferred dosage form of the present invention is oral liquid, and other oral dosage forms, such as syrup, granules, capsules, tablets, pills, etc. also belong to the category of the present invention.
本发明的优选剂型——口服液的制备方法是:Preferred dosage form of the present invention---the preparation method of oral liquid is:
1)备料:按重量份数配比称取鬼针草、野菊花、西洋参、黄芪、板蓝根、前胡、贝母、麻黄、甘草、香菇备用;1) Raw material preparation: Weigh ghost needle grass, wild chrysanthemum, American ginseng, astragalus, isatis root, peucedanum, fritillaria, ephedra, licorice, and shiitake mushrooms according to the weight ratio;
2)提取挥发物:取野菊花,水蒸气蒸馏1.5~3小时,将所得挥发油与蒸馏液按体积比1∶1收集,然后加入增溶剂,混匀后另器保存备用;增溶剂可优选聚山梨脂-80。2) Extract volatile matter: take wild chrysanthemum, steam distill for 1.5 to 3 hours, collect the obtained volatile oil and distillate according to the volume ratio of 1:1, then add solubilizing agent, mix well and store in another device for later use; the solubilizing agent can preferably be polymerized Sorbitol -80.
3)醇提:3) Alcohol extraction:
3.1)取西洋参粉碎,用60%~80%的乙醇加热回流两次,每次1.5~3小时,合并提取液,滤过,滤液回收乙醇至无醇味,浓缩液备用;3.1) Grind American ginseng, heat and reflux twice with 60% to 80% ethanol for 1.5 to 3 hours each time, combine the extracts, filter, recover the ethanol from the filtrate until it has no alcohol smell, and use the concentrated solution for later use;
3.2)取麻黄、贝母,用70%~85%的乙醇加热回流两次,每次1~2小时,合并提取液,滤过,滤液回收乙醇至无醇味,浓缩液备用;3.2) Take ephedra and Fritillaria, heat and reflux twice with 70% to 85% ethanol, each time for 1 to 2 hours, combine the extracts, filter, recover the ethanol from the filtrate until it has no alcohol smell, and use the concentrated solution for later use;
4)水提:取其余鬼针草、黄芪、板蓝根、前胡、甘草、香菇,与上述各步骤的药渣混合,加水煎煮两次,每次1.5~3小时,合并煎液,滤过,将滤液浓缩,醇沉,静置,上清液滤过,滤液回收乙醇至无醇味,浓缩液备用;4) Water extraction: take the remaining ghost needles, astragalus, isatidis, peucedanum, licorice, and shiitake mushrooms, mix them with the dregs of the above steps, add water to decoct twice, each time for 1.5 to 3 hours, combine the decoctions, and filter , concentrating the filtrate, ethanol precipitation, standing still, filtering the supernatant, recovering ethanol from the filtrate until it has no alcohol smell, and using the concentrated solution for later use;
5)将上述各备用药液及浓缩液混匀,用氢氧化钠溶液调节pH值至4.0~6.5,加水至规定量,灭菌,即得本发明的口服液。5) Mix the above-mentioned standby medicinal liquids and concentrated liquids, adjust the pH value to 4.0-6.5 with sodium hydroxide solution, add water to the specified amount, and sterilize to obtain the oral liquid of the present invention.
需要加入矫味剂时,则矫味剂是在上述步骤5)中加入的,即:将各备用药液及浓缩液混匀后加入矫味剂。When the flavoring agent needs to be added, the flavoring agent is added in the above-mentioned step 5), that is, the flavoring agent is added after each standby medicinal liquid and concentrated solution are mixed.
上述制备方法中所涉及的各工艺参数都是经过大量对比试验后得到的,按此方法可以最大限度地提取药物中的有效成分,而且所得药物的质量稳定。All the process parameters involved in the above preparation method are obtained after a large number of comparative tests. According to this method, the active ingredients in the medicine can be extracted to the greatest extent, and the quality of the obtained medicine is stable.
本口服液是纯中药制剂,吸收快、药效迅速、有效成分含量高、服用量少、口味好、安全、无毒副作用,且服用方便,尤其适合小儿服用。The oral liquid is a pure traditional Chinese medicine preparation, which has fast absorption, rapid drug effect, high active ingredient content, less dosage, good taste, safety, no side effects, and convenient administration, especially suitable for children.
本发明的糖浆剂的制备步骤1)、2)、3)、4)与上述口服液制备方法的步骤1)、2)、3)、4)对应相同,只是在步骤5)中加入的矫味剂是4.5~6.5重量份数的蔗糖,将蔗糖水煮、溶解,浓缩成糖浆,再与各备用药液及浓缩液混匀,用氢氧化钠溶液调节pH值至4.0~6.5,加水至规定量,灭菌,即得本发明的糖浆剂。The preparation steps 1), 2), 3) and 4) of the syrup of the present invention are the same as the steps 1), 2), 3) and 4) of the above-mentioned oral liquid preparation method, except that the correction agent added in step 5) The flavoring agent is 4.5-6.5 parts by weight of sucrose, which is boiled, dissolved, and concentrated into syrup, then mixed with each standby medicinal liquid and concentrated solution, adjusted to pH 4.0-6.5 with sodium hydroxide solution, and then added with water to The prescribed amount is sterilized to obtain the syrup of the present invention.
与口服液制备方法的步骤1)、2)、3)、4)对应相同,步骤5)为:将上述的步骤3)、4)获得的备用浓缩液与颗粒剂常用的辅料混合,制软材,制粒,干燥,再将上述步骤2)所得挥发油用乙醇溶解后喷于前述干燥的颗粒上,混匀,包装,即可得本发明的颗粒剂。It is the same as steps 1), 2), 3) and 4) of the oral liquid preparation method, and step 5) is: mix the spare concentrated solution obtained in the above steps 3), 4) with the commonly used auxiliary materials for granules, and make soft material, granulated, dried, and then the volatile oil obtained in the above step 2) is dissolved in ethanol and sprayed on the aforementioned dried granules, mixed evenly, and packaged to obtain the granules of the present invention.
按上述的步骤2)、3)、4)获得的备用挥发油及浓缩液后再采用常规的方法也可制成本发明的片剂、丸剂等口服剂型。在本发明的片剂、丸剂制备中也可以将西洋参、贝母打成粉末,再与其它药材提取物及常用辅料混合。The standby volatile oil and concentrated solution obtained by above-mentioned steps 2), 3), and 4) can also be made into oral dosage forms such as tablets and pills of the present invention by adopting conventional methods. In the preparation of tablets and pills of the present invention, American ginseng and Fritillaria can also be ground into powder, and then mixed with other medicinal material extracts and common auxiliary materials.
具体实施方式Detailed ways
实例1Example 1
鬼针草12份,野菊花8份,西洋参2份,黄芪30份,板蓝根20份,前胡6份,浙贝母4份,麻黄2份,甘草6份,香菇10份,蜂蜜20份。12 parts of ghost needle grass, 8 parts of wild chrysanthemum, 2 parts of American ginseng, 30 parts of astragalus, 20 parts of Radix Radix, 6 parts of peucedanum, 4 parts of fritillaria, 2 parts of ephedra, 6 parts of licorice, 10 parts of shiitake mushrooms, and 20 parts of honey.
其口服液的制备方法是:The preparation method of its oral liquid is:
1)取野菊花,水蒸气蒸馏2小时,将所得挥发油与蒸馏液按体积比1∶1收集,然后加入增溶剂——聚山梨脂-80,混匀后另器保存备用;1) Take the wild chrysanthemum flower, steam distill it for 2 hours, collect the obtained volatile oil and distillate according to the volume ratio of 1:1, then add the solubilizing agent - polysorbate-80, mix well and store in another device for later use;
3)取西洋参粉碎成粗粉,用70%的乙醇加热回流两次,每次2小时,合并提取液,滤过,滤液回收乙醇至无醇味,药液备用;3) Take American ginseng and grind it into a coarse powder, heat and reflux twice with 70% ethanol for 2 hours each time, combine the extracts, filter, recover the ethanol from the filtrate until it has no alcohol smell, and prepare the liquid for later use;
4)取麻黄、贝母,用80%的乙醇加热回流两次,每次1小时,合并提取液,滤过,回收乙醇并减压浓缩至无醇味,药液备用;4) Take ephedra and Fritillaria, heat and reflux twice with 80% ethanol for 1 hour each time, combine the extracts, filter, recover the ethanol and concentrate under reduced pressure until there is no alcohol smell, and the liquid medicine is set aside;
5)取其余鬼针草、黄芪、板蓝根、前胡、甘草、香菇,与上述各步骤的药渣混合,加水煎煮两次,每次2小时,合并煎液,滤过,将滤液浓缩至相对密度为1.1~1.2(60℃)的清膏,再加入乙醇至含醇量达60%,静置,滤过,滤液回收乙醇至无醇味,药液备用;5) Take the remaining ghost needles, astragalus, isatidis, peucedanum, licorice, and shiitake mushrooms, mix them with the dregs of the above steps, add water and decoct twice for 2 hours each time, combine the decoctions, filter, and concentrate the filtrate to For the clear ointment with a relative density of 1.1-1.2 (60°C), add ethanol until the alcohol content reaches 60%, let it stand, filter, recover the ethanol from the filtrate until it has no alcohol smell, and prepare the liquid medicine for later use;
6)将上述各备用药液及浓缩液混匀,再加入20份蜂蜜,搅匀,用2mol/L的氢氧化钠溶液调节pH值至6.5,加水至规定量,灭菌,即得本发明的治疗小儿感冒及反复感冒的口服液。6) Mix the above-mentioned standby medicinal liquids and concentrates, then add 20 parts of honey, stir well, adjust the pH value to 6.5 with 2mol/L sodium hydroxide solution, add water to the specified amount, and sterilize to obtain the present invention. Oral solution for treating colds and recurrent colds in children.
实例2Example 2
取鬼针草5份,野菊花15份,西洋参1份,黄芪40份,板蓝根15份,前胡8份,浙贝母8份,麻黄4份,甘草8份,香菇12.5份,蜂蜜20份。其口服液的制备方法同实例1。Take 5 parts of ghost needle grass, 15 parts of wild chrysanthemum, 1 part of American ginseng, 40 parts of astragalus, 15 parts of Radix Isatidis, 8 parts of peucedanum, 8 parts of fritillaria, 4 parts of ephedra, 8 parts of licorice, 12.5 parts of shiitake mushrooms, and 20 parts of honey . The preparation method of its oral liquid is with example 1.
实例3Example 3
取鬼针草15份,野菊花5份,西洋参4份,黄芪20份,板蓝根15份,前胡4份,浙贝母3份,麻黄1.5份,甘草4份,香菇11份,蜂蜜20份。其口服液的制备方法同实例1。Take 15 parts of ghost needle grass, 5 parts of wild chrysanthemum, 4 parts of American ginseng, 20 parts of astragalus, 15 parts of Radix Radix, 4 parts of peucedanum, 3 parts of fritillaria, 1.5 parts of ephedra, 4 parts of licorice, 11 parts of shiitake mushrooms, and 20 parts of honey . The preparation method of its oral liquid is with example 1.
实例4Example 4
取鬼针草11份,野菊花11份,西洋参3份,黄芪35份,板蓝根17份,前胡5份,浙贝母6份,麻黄3份,甘草6份,香菇9.5份,蜂蜜20份。其口服液的制备方法同实例1。Take 11 parts of ghost needle grass, 11 parts of wild chrysanthemum, 3 parts of American ginseng, 35 parts of astragalus, 17 parts of Radix Isatidis, 5 parts of peucedanum, 6 parts of fritillaria, 3 parts of ephedra, 6 parts of licorice, 9.5 parts of shiitake mushrooms, and 20 parts of honey . The preparation method of its oral liquid is with example 1.
本申请人通过大量临床试验证明,以上实施例均可达到较好的效果。The applicant has proved through a large number of clinical trials that the above embodiments can all achieve good results.
毒性试验Toxicity test
试验药品是本发明的制剂,每1ml口服液含原药材1g。试验动物为ICR种小白鼠,体重20g±2g,雌雄各半,共20只。试验单位:西安交通大学临床病理研究所。试验方法是:禁食12小时后,按20g/Kg(是推荐临床剂量的120倍)给小白鼠灌胃,然后观察7天,未见有明显毒性。按10g/Kg剂量给小白鼠连续灌胃3个月,亦未见异常。表明该药的安全性大,属无毒级别。The test drug is the preparation of the present invention, and every 1ml of oral liquid contains 1g of the original medicinal material. The test animals are ICR white mice, weighing 20g±2g, male and female, 20 in total. Test unit: Institute of Clinical Pathology, Xi'an Jiaotong University. The test method is: after 12 hours of fasting, 20g/Kg (120 times of the recommended clinical dose) is given to mice orally, and then observed for 7 days, no obvious toxicity is seen. According to the dose of 10g/Kg, the mice were continuously gavaged for 3 months, and no abnormalities were found. Show that the safety of the drug is large, belonging to non-toxic level.
临床试验Clinical Trials
试验对象为确诊为上呼吸道感染的患儿;疗效判定标准参照全国防治感冒科研协作座谈会制定的《感冒与流感诊断要点与防治效果判定标准(草案)》;试验单位有陕西省中医药研究院附属医院、西安交通大学第一附属医院等四所医院;试验方法采用平行对照设计,随机分组。试验组服用本发明的口服液,规格为10ml/支。1岁以下,每次1/2支,一日3次;1~3岁每次1支,一日3次;3~6岁,每次1支,一日4次;6~12岁,每次1支,1日5次。对照组服用《清热解毒口服液》,河南省洛阳民生制药厂生产。The subjects of the test were children diagnosed with upper respiratory tract infection; the curative effect was determined according to the "Cold and Influenza Diagnosis Key Points and Prevention and Control Effect Judgment Standard (Draft)" formulated by the National Collaborative Symposium on Prevention and Control of Cold Research; the test unit was Shaanxi Academy of Traditional Chinese Medicine Four hospitals including the Affiliated Hospital and the First Affiliated Hospital of Xi'an Jiaotong University; the experimental method adopts a parallel control design and is randomly divided into groups. Test group takes oral liquid of the present invention, and specification is 10ml/ supports. Under 1 year old, take 1/2 stick each time, 3 times a day; 1-3 years old, take 1 stick each time, 3 times a day; 3-6 years old, take 1 stick each time, 4 times a day; 6-12 years old, take 1 stick each time, 4 times a day; 1 stick each time, 5 times a day. The control group took "Qingrejiedu Oral Liquid", produced by Luoyang Minsheng Pharmaceutical Factory in Henan Province.
临床试验结果如下:The clinical trial results are as follows:
1)急性上感:共观察病例152例,结果见表1。1) Acute upper flu: A total of 152 cases were observed, and the results are shown in Table 1.
表1
对照组的总有效率为84.4%。The total effective rate of the control group was 84.4%.
2)小儿经常感冒:试验组共观察112例,结果见表22) Frequent colds in children: A total of 112 cases were observed in the test group, the results are shown in Table 2
表2
对照组的总有效率为86.0%。The total effective rate of the control group was 86.0%.
以上可以看出,本发明的疗效显著,特别是对小儿经常感冒的治疗有效率达91.1%。As can be seen from the above, the curative effect of the present invention is remarkable, especially the effective rate of treating common colds in children reaches 91.1%.
本发明的口服液经西安交通大学临床药理研究所进行的药效学试验表明:本口服液具有显著的解热、镇痛、镇咳作用,明显的抗炎作用,显著的松弛支气管平滑肌的作用(即有平喘效果)。本口服液具有较强的广谱抗病毒作用,特别是对呼吸道病毒作用更显著,但对腺病毒作用不明显。试验还表明本口服液具有显著的增强细胞免疫功能的作用。The oral liquid of the present invention shows through the pharmacodynamics test that Xi'an Jiaotong University Institute of Clinical Pharmacology carries out: this oral liquid has significant antipyretic, analgesic, antitussive effect, obvious anti-inflammatory effect, and the effect of significant relaxation bronchial smooth muscle (That is, there is an antiasthmatic effect). The oral liquid has a strong broad-spectrum antiviral effect, especially a more significant effect on respiratory virus, but not obvious effect on adenovirus. Tests also show that the oral liquid has a significant effect of enhancing cellular immune function.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100429380A CN100344313C (en) | 2005-07-14 | 2005-07-14 | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100429380A CN100344313C (en) | 2005-07-14 | 2005-07-14 | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1724040A true CN1724040A (en) | 2006-01-25 |
CN100344313C CN100344313C (en) | 2007-10-24 |
Family
ID=35923758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100429380A Active CN100344313C (en) | 2005-07-14 | 2005-07-14 | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100344313C (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102335303A (en) * | 2011-10-20 | 2012-02-01 | 广州一品红制药有限公司 | Chinese medicinal effective-part composition for treating cold in children and preparation method thereof |
CN102614352A (en) * | 2011-02-01 | 2012-08-01 | 王平平 | Traditional Chinese medicine composition for treating infantile common cold, its preparation method and detection method |
CN103417645A (en) * | 2012-05-18 | 2013-12-04 | 北京创立科创医药技术开发有限公司 | Traditional Chinese medicine compound for curing cough caused by weakness of elder people |
CN103705561A (en) * | 2014-01-03 | 2014-04-09 | 刘扬 | American ginseng berry pharmaceutical composition and preparation method and application thereof |
CN104666832A (en) * | 2015-03-20 | 2015-06-03 | 广州一品红制药有限公司 | Traditional Chinese medicinal granule for treating cold and repeated cold, and preparation method for traditional Chinese medicinal granule |
CN104689036A (en) * | 2015-03-13 | 2015-06-10 | 广州一品红制药有限公司 | Oral liquid for treating common cold in children and repeated cold and preparation method of oral liquid |
CN104706918A (en) * | 2015-03-13 | 2015-06-17 | 广州一品红制药有限公司 | Traditional Chinese medicine sirup for treating common cold in children and preparation method of traditional Chinese medicine sirup |
CN105327116A (en) * | 2015-11-06 | 2016-02-17 | 李艺腾 | Traditional Chinese medicine composition for treating children with reccurent respiratory tract infections |
CN105396105A (en) * | 2015-12-10 | 2016-03-16 | 杨献美 | A method of preparing a traditional Chinese medicine composition for preventing and treating recurrent common cold in children |
CN105412872A (en) * | 2015-12-10 | 2016-03-23 | 杨献美 | Traditional Chinese medicine combination for preventing infantile repeated colds |
CN105477430A (en) * | 2015-12-30 | 2016-04-13 | 暨南大学 | Traditional Chinese medicine preparation containing folium artemisiae argyi for preventing and/or treating infantile repeated colds |
CN112402544A (en) * | 2020-11-11 | 2021-02-26 | 广州一品红制药有限公司 | Application of fragrant-flavor cinnoline oral liquid in preparation of medicine for preventing and/or treating asthma and diminishing inflammation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634244A (en) * | 2004-09-24 | 2005-07-06 | 贵阳云岩西创药物科技开发有限公司 | Chinese medicinal formulation for treating children's cold and its preparation method |
-
2005
- 2005-07-14 CN CNB2005100429380A patent/CN100344313C/en active Active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614352A (en) * | 2011-02-01 | 2012-08-01 | 王平平 | Traditional Chinese medicine composition for treating infantile common cold, its preparation method and detection method |
CN102335303A (en) * | 2011-10-20 | 2012-02-01 | 广州一品红制药有限公司 | Chinese medicinal effective-part composition for treating cold in children and preparation method thereof |
CN102335303B (en) * | 2011-10-20 | 2013-07-10 | 广州一品红制药有限公司 | Chinese medicinal effective-part composition for treating cold in children and preparation method thereof |
CN103417645A (en) * | 2012-05-18 | 2013-12-04 | 北京创立科创医药技术开发有限公司 | Traditional Chinese medicine compound for curing cough caused by weakness of elder people |
CN103705561A (en) * | 2014-01-03 | 2014-04-09 | 刘扬 | American ginseng berry pharmaceutical composition and preparation method and application thereof |
CN104689036A (en) * | 2015-03-13 | 2015-06-10 | 广州一品红制药有限公司 | Oral liquid for treating common cold in children and repeated cold and preparation method of oral liquid |
CN104706918A (en) * | 2015-03-13 | 2015-06-17 | 广州一品红制药有限公司 | Traditional Chinese medicine sirup for treating common cold in children and preparation method of traditional Chinese medicine sirup |
CN104666832A (en) * | 2015-03-20 | 2015-06-03 | 广州一品红制药有限公司 | Traditional Chinese medicinal granule for treating cold and repeated cold, and preparation method for traditional Chinese medicinal granule |
CN105327116A (en) * | 2015-11-06 | 2016-02-17 | 李艺腾 | Traditional Chinese medicine composition for treating children with reccurent respiratory tract infections |
CN105327116B (en) * | 2015-11-06 | 2019-06-18 | 李艺腾 | A kind of Chinese medicine composition for treating Chinese medicinel |
CN105396105A (en) * | 2015-12-10 | 2016-03-16 | 杨献美 | A method of preparing a traditional Chinese medicine composition for preventing and treating recurrent common cold in children |
CN105412872A (en) * | 2015-12-10 | 2016-03-23 | 杨献美 | Traditional Chinese medicine combination for preventing infantile repeated colds |
CN105477430A (en) * | 2015-12-30 | 2016-04-13 | 暨南大学 | Traditional Chinese medicine preparation containing folium artemisiae argyi for preventing and/or treating infantile repeated colds |
CN112402544A (en) * | 2020-11-11 | 2021-02-26 | 广州一品红制药有限公司 | Application of fragrant-flavor cinnoline oral liquid in preparation of medicine for preventing and/or treating asthma and diminishing inflammation |
Also Published As
Publication number | Publication date |
---|---|
CN100344313C (en) | 2007-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768308B (en) | A kind of pharmaceutical composition that is used for the treatment of the infection of the upper respiratory tract and preparation method thereof | |
CN103099948A (en) | Pharmaceutical composition for treating pharyngitis and preparation method | |
CN1883560A (en) | A compound Chinese medicinal preparation containing Chinese globeflower and method for preparing same | |
CN1724040A (en) | Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method | |
CN1251732C (en) | Chinese medicine for treating intrapulmonic infection and SARS | |
CN1221277C (en) | Prophylaxis medication for treating pneumonia, bronchitis, pharyngitis and upper respiratory tract infection as well as its preparing method | |
CN104983968B (en) | Antipyretic traditional Chinese medicine composition and preparation method thereof | |
CN1895606A (en) | Heat-clearing and toxicity-relieving Chinese-medicinal preparation with phlegm-resolving and cough-relieving functions and its making method | |
CN105343660A (en) | Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation | |
CN1278709C (en) | Medicine for treating cold and its preparing process | |
CN102429980A (en) | Cold granules and preparation method thereof | |
CN102631492B (en) | Chinese medicinal composition for improving immunity and resisting fatigue | |
CN1931262A (en) | Common cold treating Chinese medicine prepn | |
CN1237998C (en) | Effervescence tablet for treating children's cough and asthma and its preparation | |
CN1876044A (en) | A Chinese medicinal composition for treating infant fever caused by exogenous pathogen and preparation method thereof | |
CN112168947A (en) | Traditional Chinese medicine composition for treating pneumonia and preparation method thereof | |
CN1231242C (en) | Medication composition for children 's virus pneumonia and its preparation method | |
CN103705599B (en) | A kind of pharmaceutical composition for the treatment of cough and preparation method thereof | |
CN113304218B (en) | Traditional Chinese Medicine for Feline Calicivirus Infection | |
CN102631486B (en) | Health care composition | |
CN102631506B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
CN1634340A (en) | A pharmaceutical composition for preventing and treating children's respiratory diseases and its preparation method | |
CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
CN102949681A (en) | Composition for preventing or treating colds, and its preparation method | |
CN1234395C (en) | Medicinal tea of infused in boiling water and its production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YUNNAN YIPINHONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: RONGSHA PHARMACEUTICAL CO., LTD., SHAANXI Effective date: 20110525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 714000 NO. 102, WEST SECTION OF DONGFENG ROAD, ECONOMIC DEVELOPMENT ZONE, WEINAN CITY, SHAANXI PROVINCE TO: 661100 WEST SIDE OF SOUTH SECTION OF HAIBIN ROAD, MENGZI COUNTY, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110525 Address after: 661100 west side of South section of Haibin Road, Mengzi County, Yunnan Province Patentee after: Yunnan yipinhong Pharmaceutical Co.,Ltd. Address before: 714000 No. 102 west section of Dongfeng Road, Weinan Economic Development Zone, Shaanxi, China Patentee before: Rongsha Pharmaceutical Co.,Ltd. Shaanxi |
|
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU VANKING PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YUNNAN YIPINHONG PHARMACEUTICAL CO., LTD. Effective date: 20120929 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 661100 HONGHE HANI AND YI AUTONOMOUS PREFECTURE, YUNNAN PROVINCE TO: 510730 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120929 Address after: 510730 Guangdong Province east of Guangzhou economic and Technological Development Zone No. 6 self building Patentee after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Address before: 661100 west side of South section of Haibin Road, Mengzi County, Yunnan Province Patentee before: Yunnan yipinhong Pharmaceutical Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese patent drug for treating infantile cold and repeated cold, and its prepn. method Effective date of registration: 20140703 Granted publication date: 20071024 Pledgee: Industrial Commercial Bank of China Ltd. Guangzhou branch Yuexiu Pledgor: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Registration number: 2014440000011 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Youmin Inventor after: Li Hanxiong Inventor before: Wang Youmin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG YOUMIN TO: WANG YOUMIN LI HANXIONG |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20071024 Pledgee: Industrial Commercial Bank of China Ltd. Guangzhou branch Yuexiu Pledgor: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Registration number: 2014440000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20250110 Address after: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Patentee after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Country or region after: China Patentee after: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Patentee after: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Patentee after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Patentee after: Euphorbia Biological Medicine Co.,Ltd. Address before: 510730 Building 1, No.6 Dongbo Road, Guangzhou Economic and Technological Development Zone, Guangdong Province Patentee before: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Country or region before: China |